HAVRIX 1440 [iU]/mL
Hepatitis A Vaccine · INJECTION, SUSPENSION · GlaxoSmithKline Biologicals SA
HAVRIX is a injection, suspension containing hepatitis a vaccine at 1440 [iU]/mL, taken intramuscular. Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- HAVRIX
- Generic Name
- Hepatitis A Vaccine
- NDC Code (Product)
58160-826- Manufacturer
- GlaxoSmithKline Biologicals SA
- Strength
- 1440 [iU]/mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103475
- Marketing Start
- 04/13/2007
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
USES: • For the temporary relief of symptoms including: • fever • fatigue • headache • muscle aches and pains • rash These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Dosage & Administration
DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.
Frequently Asked Questions
What is HAVRIX used for?
HAVRIX contains Hepatitis A Vaccine. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is HAVRIX a controlled substance?
HAVRIX is not classified as a controlled substance by the DEA.
What is the generic name for HAVRIX?
The generic name for HAVRIX is Hepatitis A Vaccine. There are 4 other brand versions of Hepatitis A Vaccine.
What is the NDC code for HAVRIX 1440 [iU]/mL?
The NDC (National Drug Code) for HAVRIX 1440 [iU]/mL is 58160-826, listed by GlaxoSmithKline Biologicals SA.